KURA Gross Margin

The Gross Margin of Kura Oncology Inc (KURA) is 99.92%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

KURA Gross Margin - Historical Value

Date	Value
2024-12-31	99.92%

KURA Gross Margin - Peers Comparison

Ticker	Name	Value
ARQT	Arcutis Biotherapeutics Inc	90.24%
MCRB	Seres Therapeutics Inc	7775.20%
ABBV	AbbVie Inc	71.62%
DMTK	DermTech Inc	1.80%
KNTE	Kinnate Biopharma Inc	7775.20%
YMAB	Y-mAbs Therapeutics Inc	82.89%
OCGN	Ocugen Inc	7775.20%
REPL	Replimune Group Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.24%
950220.KQ	Neoimmunetech Inc	7775.20%
AMGN	Amgen Inc	82.52%
CCCC	C4 Therapeutics Inc	7775.20%
KRON	Kronos Bio LLC	7775.20%
MYOV	Myovant Sciences Ltd	77.68%
ZYME	Zymeworks Inc	7775.20%
950200.KQ	Psomagen Inc	21.92%
CGEM	Cullinan Therapeutics Inc	7775.20%
CYTK	Cytokinetics Inc	7775.20%
KRYS	Krystal Biotech Inc	94.08%
PMVP	PMV Pharmaceuticals Inc	7775.20%
GILD	Gilead Sciences Inc	78.84%
ALVR	Allovir Inc	7775.20%
GBIO	Generation Bio Inc	7775.20%
IMVT	Immunovant Inc	7775.20%
MRNA	Moderna Inc	70.32%
STOK	Stoke Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	86.56%
STTK	Shattuck Labs Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
ALEC	Alector Inc	7775.20%
NKTX	Nkarta Inc	7775.20%
NRIX	Nurix Therapeutics Inc	7775.20%
OLMA	Olema Pharmaceuticals Inc	7775.20%
VBIV	VBI Vaccines Inc	-44.06%